Skip to main content
Premium Trial:

Request an Annual Quote

Rush Wins $750K DoD Grant for Gut Microbe Study

NEW YORK (GenomeWeb News) – Chicago's Rush University Medical Center has received a $750,000 grant from the US Department of Defense to study the microbes in the human gut to find out if they may play a role in breast cancer and other diseases, Rush said today.

The hospital said that microbes of the gut have been overlooked as a potential cause of breast cancer, particularly when compared with gene variants and environmental factors.

The research will focus on genomics studies of the human gastrointestinal microbiota and how it may be involved in carcinogens and sex hormone metabolism, based on research that has shown that these microbes may affect estrogen balance and metabolism. Data from the study could offer information about other diseases related to hormones, such as ovarian cancer, osteoporosis, and endometriosis.

The researchers will use multitag pyrosequencing to barcode and identify 50,000 to 60,000 microbes per sample, Rush said.

Rush is recruiting women who are at least 30 years old and are newly diagnosed with breast cancer so that it may collect biopsies of the colon and stool samples before the patients receive any cancer therapy.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.